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erythropoietin; maximal oxygen uptake; athletes

of “live high-train low” (HiLo)
has been shown repeatedly to improve sea level endurance
exercise performance and maximal oxygen uptake (V̇O2max) in
cohorts of elite (37, 40, 43, 45) and subelite (27) endurance
athletes. These improvements in performance have been
linked, in large part, to the hematological acclimatization
response to altitude (i.e., an increase in the oxygen-carrying
capacity of the blood) (7, 15, 26). Outcomes from our laboratory’s previous work show an average acute erythropoietin
(EPO) increase at moderate altitude to ⬃150% of sea level
baseline and average red cell mass (measured from the erythrocyte volume, defined as blood volume ⫺ plasma volume)
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Address for reprint requests and other correspondence: B. D. Levine,
Institute for Exercise and Environmental Medicine, 7232 Greenville Ave.,
Dallas, TX 75231 (e-mail: BenjaminLevine@texashealth.org).
http://www.jappl.org

increases of ⬃1.5–2.0 ml/kg after 4 wk of altitude residence
(12, 24, 27, 43). In these investigations, we have utilized a
common altitude training site (Deer Valley, Salt Lake City,
UT) with a fixed moderate living altitude of 2,500 m. While
chronic living at 2,500 m has provided a robust enough
hypoxic stimulus to cause significant hematological acclimatization in the majority of athletes, the responses of EPO and red
cell mass to a given altitude show substantial individual variability (12, 17, 18, 21, 42). In fact, many athletes have shown
a relatively mild acute and chronic EPO response to altitude,
leading to no changes in red cell volume, V̇O2max, or sea level
track performance, despite 4 wk of chronic exposure to ⬎2,500
m (12, 18). Indeed, when this erythropoietic response is absent,
there is little evidence that altitude works to improve endurance
performance (42). These data would suggest that there may be
a minimum threshold living altitude or hypoxic “dose” for
adequate hematological acclimatization, and thus performance
enhancement, in athletes completing altitude training regimens
(25, 31, 34, 44, 47, 48).
To examine the threshold altitude concept for hematological
responses, our laboratory previously studied 48 athletes using
separate 24-h hypobaric chamber exposures to four simulated
altitudes of 1,780, 2,085, 2,454, and 2,800 m (17). While these
athletes also showed large interindividual variability of 24-h
EPO responses to altitude, the data suggested that the altitudeinduced increase in EPO is largely dependent on the hypoxic
dose. Although EPO was significantly elevated over sea level
baseline after 6 and 24 h at all four simulated altitudes, the
EPO response to the two highest simulated altitudes (2,454 and
2,800 m) was significantly higher (⬃3 times as large at 24 h)
as the EPO response to 1,780 and 2,085 m. This response
would suggest that a threshold altitude of ⬃2,100 –2,500 m
may exist to attain a sustained increase in group EPO response
over 24 h (17, 31, 47). If so, the outcomes of many altitude
training studies could be largely influenced by the living
altitude utilized, particularly if the living altitude is below this
suggested 2,100- to 2,500-m threshold. Ultimately, it remains
unknown if chronic residence at differing strata of terrestrial
altitudes will show the same hematological responses as shortterm exposure to simulated altitudes. For the athlete engaged in
altitude training, the identification of an optimal living altitude
holds tremendous practical application.
Therefore, the purpose of this study was to examine the
physiological and performance responses of athletes completing a 4 wk HiLo altitude training camp, with athletes assigned
to one of four different locations of living altitude between
1,780 and 2,800 m. Based on current knowledge, we hypoth-
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Chapman RF, Karlsen T, Resaland GK, Ge RL, Harber MP,
Witkowski S, Stray-Gundersen J, Levine BD. Defining the “dose”
of altitude training: how high to live for optimal sea level performance
enhancement. J Appl Physiol 116: 595– 603, 2014. First published
October 24, 2013; doi:10.1152/japplphysiol.00634.2013.—Chronic
living at altitudes of ⬃2,500 m causes consistent hematological
acclimatization in most, but not all, groups of athletes; however,
responses of erythropoietin (EPO) and red cell mass to a given altitude
show substantial individual variability. We hypothesized that athletes
living at higher altitudes would experience greater improvements in
sea level performance, secondary to greater hematological acclimatization, compared with athletes living at lower altitudes. After 4 wk of
group sea level training and testing, 48 collegiate distance runners (32
men, 16 women) were randomly assigned to one of four living
altitudes (1,780, 2,085, 2,454, or 2,800 m). All athletes trained
together daily at a common altitude from 1,250 –3,000 m following a
modified live high-train low model. Subjects completed hematological, metabolic, and performance measures at sea level, before and
after altitude training; EPO was assessed at various time points while
at altitude. On return from altitude, 3,000-m time trial performance
was significantly improved in groups living at the middle two altitudes
(2,085 and 2,454 m), but not in groups living at 1,780 and 2,800 m.
EPO was significantly higher in all groups at 24 and 48 h, but returned
to sea level baseline after 72 h in the 1,780-m group. Erythrocyte
volume was significantly higher within all groups after return from
altitude and was not different between groups. These data suggest
that, when completing a 4-wk altitude camp following the live
high-train low model, there is a target altitude between 2,000 and
2,500 m that produces an optimal acclimatization response for sea
level performance.
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esized that groups living at relatively higher altitude would
demonstrate greater improvements in sea level performance
measures, secondary to greater hematological acclimatization.
MATERIALS AND METHODS

Subjects

Study Protocol
The study protocol was a modified version of previous protocols
developed by the authors (27, 43). In the first phase of the study, 4 wk
of supervised sea level training in Dallas, Texas were performed,
during which exercise testing, simulated altitude exposure, blood
testing, and iron maintenance or replacement therapy were initiated.
In the second phase of the study, subjects were transported by airplane
to Salt Lake City, Utah. Subjects were randomly assigned to one of
four groups, and each group of subjects was transported by car to
different locations at different altitudes in the Wasatch mountain area
for a 28-day altitude training camp. In the third phase of the study,
subjects returned by airplane to Dallas for 3 wk of sea level follow-up
testing. The study protocol is displayed in Fig. 1. While in Dallas, all
subjects were housed in the same corporate apartment housing complex. In Utah, subjects in each altitude group were housed in comparable vacation condominiums, typical of a ski resort area. Subjects
slept one or two to a bedroom. Although food intake was not
controlled, weekly grocery shopping trips were supervised by research
staffers to ensure healthy food choices were purchased.

Fig. 1. Study timeline. Subjects completed 4 wk of sea level (SL) training,
followed by 4 wk of HiHiLo altitude training (i.e., moderate altitude living,
moderate altitude low-intensity base training, and high-intensity training at low
altitude) (with groups assigned to different living altitudes), and 2 wk of
postaltitude training at SL. Testing was completed at various time points
throughout the experiment (see MATERIALS AND METHODS). EPO, erythropoietin.

Chapman RF et al.

Altitude Training Camp
Subjects were matched by sex, training history, V̇O2max, and 3-km
time in groups of four and then assigned in a balanced randomization
to housing at four different altitudes in the Wasatch Mountain region
near Salt Lake City. Four women and eight men were randomly
assigned to each of the four altitudes, with slight adjustments in group
assignments made before departure for altitude so that the mean 24-h
EPO response to a simulated altitude of 2,454 m was similar between
groups (see below under Assessments: Decompression chamber exposure). Subjects lived at Heber City (1,780 m), Park City (2,085 m),
Deer Valley (2,454 m), or Guardsman’s Pass (2,800 m). During the
training camp, subjects were requested to spend the majority of time
at their living altitude and were supervised by a staff member to
ensure compliance. With some exceptions, subjects gathered daily for
supervised training at the same altitude and location (between 1,250
and 3,000 m), regardless of the subjects’ assigned living altitude. This
effectively standardized the training altitude across all subjects for
each day of the altitude exposure. Training followed the “HiHiLo”
model of HiLo altitude training (i.e., moderate altitude living, moderate altitude low-intensity base training, and high-intensity training at
low altitude) (43). Low intensity and moderate “base” training took
place at moderate altitudes (1,780 –3,000 m), while higher intensity
runs and aerobic interval training sessions were performed at the
lowest possible altitude in Salt Lake City (1,250 m). All subjects
received daily liquid iron supplementation (Feo-Sol, 9 mg elemental
iron/ml) during both the 4-wk sea level and 4-wk altitude training
camps, in doses based on prealtitude plasma ferritin concentration
(5– 45 ml/day). In testing the week before altitude exposure, all men
had serum ferritin levels ⬎30 ng/ml, and all women were ⬎20 ng/ml.
Assessments
Treadmill assessment. Submaximal oxygen uptake (V̇O2) and
V̇O2max were tested at sea level (Dallas, Texas) at four time points
throughout the study, with the submaximal data published previously
(28). Test 1 was performed on initial athlete arrival for the study, test
2 after 4 wk of sea level training in Dallas, test 3 within the first 48
h after returning from altitude to Dallas, and test 4 occurring 2 wk
after returning to sea level. In the submaximal protocol, after a 15-min
warm-up on the treadmill, subjects ran at a constant velocity of
14.4 km/h (9 mph). Metabolic variables [minute ventilation (V̇E),
V̇O2, heart rate] were recorded from the 4th min of this exercise bout.
For the maximal exercise protocol, subjects ran to volitional exhaustion following a modified Astrand/Saltin protocol (4). Subjects ran at
a constant velocity of 14.4 km/h (9 mph) for men and 12.8 km/h (8
mph) for women at a 0% grade for 2 min, with the grade increasing
2% every 2 min until exhaustion. V̇O2 was measured via the Douglas
bag method, with fractional gas concentrations determined by mass
spectroscopy (Marquette MGA 1100, Milwaukee, WI) and ventilatory
volumes by a dry gas meter (Collins, Boston, MA). Maximal heart
rate was measured from telemetry (Polar, Finland).
Performance. Sea level performance was assessed by 3,000-m time
trial races on a 400-m track in Dallas, Texas. Two time trial races
were performed before, and two time trial races were performed after,
the altitude training camp, each within 1–2 days of the V̇O2max test.
The time trial races were held between 0700 and 0800 in the morning
and were run in separate women’s and men’s heats. Subjects were
instructed to achieve the best time possible in each race. Experienced
pace setters (athletes not involved in the study) were utilized to set a
fast, competitive pace for the first 1,600 m of the 3,000-m race to
ensure physiological rather than tactical performance. The pace setter
or “rabbit” ran the same preselected race pace in all time trials. Time
was recorded for each athlete to the nearest 0.1 s.
Hematology assessment. Plasma volume, blood volume, and erythrocyte volume (blood volume ⫺ plasma volume) were measured once
at sea level before the altitude training camp and twice after the
altitude training camp. Plasma volume was measured by using the
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Forty-eight collegiate track and cross country runners (32 men and
16 women, 21 ⫾ 2 yr, 64.0 ⫾ 8.4 kg, 174 ⫾ 9 cm) volunteered to
participate in the study and gave their informed consent after receiving information of the study protocol. Data from this cohort on
responses to acute hypobaric hypoxia (16, 17) and submaximal
exercise (28) have been published elsewhere. Exclusion criteria included altitude residence (⬎1,500 m) longer than 7 days in the
previous 10 mo, permanent altitude residence of ⬎3 mo during their
lifetimes, or injury or illness that impaired normal training and racing
before the study. All subjects gave written, informed consent to a
protocol approved by the Institutional Review Board of the University
of Texas Southwestern Medical Center at Dallas and Presbyterian
Hospital of Dallas.
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outs (e.g., interval sessions, long runs, tempo efforts) together on the
same day of the week, so that an overall group training milieu could
be established.
Oxygenation during sleep. Arterial oxyhemoglobin saturation
(SaO2) during sleep was determined by pulse oximetry (Ohmeda 3700,
Louisville, CO). Measures were taken between 0400 and 0600 on the
mornings, corresponding to 24-, 48-, and 72-h, and 1-, 2-, and 3-wk
time points after arrival at altitude. These measures were utilized to
document the desaturation differences between groups in relation to
EPO production, as well as a potential marker affecting the quality of
sleep and recovery.
Statistical Analysis
Data were analyzed using IBM SPSS version 20 statistical software. All data values are reported as means ⫾ SD, except where
noted. A Shapiro-Wilk test was utilized, and all dependent variables
were determined to be normally distributed. Therefore, parametric
statistics was used in all further analyses. Two-way split plot repeatedmeasures ANOVA with a priori tests of simple main effects (and
Fisher’s least significant difference post hoc analysis) were used to
determine differences in dependent measures at different time points
within altitude groups. The same procedure was also used to determine differences in dependent measures between altitude groups at
the same time point. One-way ANOVAs were used to determine
differences in baseline subject characteristics between altitude groups.
The ␣-level for significance was set at P ⬍ 0.05.
RESULTS

Subjects
A total of 45 athletes (29 men and 16 women) successfully
completed the full protocol. One athlete dropped out before
travel to altitude for personal reasons, one was in a car accident
in Utah and was unable to complete the altitude exposure,
and one became ill and was unable to complete the postaltitude testing (all men; two from the 1,780-m group and one
from the 2,085-m group). Subject characteristics are displayed
in Table 1. No differences in physical characteristics, V̇O2max,
ferritin stores, or change in EPO concentration after 24 h of
chamber exposure to a simulated altitude of 2,454 m were
detected between the different living altitude groups at inclusion in the study.
Training
Training volume during the altitude training camp was not
different between the four altitude living groups, and neither
was the number of self-classified high-intensity workouts. The
total volume of miles (1.609 km) run per person was 227 ⫾ 48,
219 ⫾ 57, 215 ⫾ 54, and 221 ⫾ 56 mi. in the athletes living
at 1,780, 2,085, 2,454, and 2,800 m, respectively. The number

Table 1. Subject characteristics
Living Altitude

Men/women, no. of subjects
Age, yr
Height, cm
Mass, kg
V̇O2max, ml·kg⫺1·min⫺1
Serum ferritin, ng/ml
⌬EPO after 24-h chamber exposure at 2,454 m, %

1,780 m

2,085 m

2,545 m

2,800 m

6/4
21.4 ⫾ 3.1
175.5 ⫾ 10.1
64.7 ⫾ 9.3
63.9 ⫾ 4.8
33 ⫾ 15
110 ⫾ 73

7/4
20.1 ⫾ 1.5
174.7 ⫾ 7.9
64.2 ⫾ 8.4
61.9 ⫾ 6.7
27 ⫾ 7
116 ⫾ 74

8/4
20.7 ⫾ 1.6
171.8 ⫾ 8.6
62.6 ⫾ 8.0
61.3 ⫾ 7.2
34 ⫾ 15
106 ⫾ 88

8/4
21.2 ⫾ 2.2
175.3 ⫾ 10.2
64.3 ⫾ 9.2
62.0 ⫾ 7.1
39 ⫾ 17
103 ⫾ 91

Values are means ⫾ SD. V̇O2max, maximal oxygen uptake; EPO, serum erythropoietin concentration; ⌬, change.
J Appl Physiol • doi:10.1152/japplphysiol.00634.2013 • www.jappl.org
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Evans blue dye indicator-dilution technique (32). Subjects rested
quietly for at least 30 min in the supine position, a known quantity of
Evans blue dye was injected through a catheter placed in a peripheral
vein, and venous blood was drawn at 10, 20, and 30 min after injection
for the measurements of absorbance at 620 and 740 nm via spectrophotometry (model DU 600 Beckman, Brea, CA). Hematocrit was
measured via microcentrifuge, and blood volume was estimated by
dividing plasma volume by 1 minus hematocrit, using appropriate
corrections for trapped plasma and peripheral sampling (14). Total red
cell volume was defined as blood volume minus plasma volume. This
method has been compared recently in a different group of athletes
against the carbon monoxide rebreathing technique with excellent
agreement for the assessment of blood compartment volumes (r2 ⫽
0.85; 3% difference between methods) (20).
Decompression chamber exposure. The protocol and the outcomes
from the same subject sample utilized in this study have been
published previously (17). Briefly, each week for a total of 4 wk
before departure to altitude, subjects spent 24 h in a decompression
chamber at simulated altitudes of 1,780, 2,085, 2,454, and 2,800 m in
a pseudo-random order (the last simulated altitude for all subjects was
fixed a priori at 1,780 m to minimize the effect of the chamber
exposures on subsequent experiments conducted in the field). The
simulated altitudes were chosen to match the terrestrial altitudes
utilized in the study. Subjects were blinded to all simulated altitudes,
and, when decompression was started, the chamber operator would
briefly “bounce” the simulated altitude over a wide range before
settling at the treatment altitude. For comfort, only 12 athletes were in
the chamber during any 24-h exposure. The temperature (25 ⫾ 0.5°C),
humidity (28 ⫾ 1%), and CO2 concentration (0.07 ⫾ 0.02%) in the
chamber was carefully controlled.
EPO concentration. During the chamber exposure, EPO concentration was measured at sea level (before decompression) and after 6
and 24 h at each simulated altitude in the decompression chamber.
During the altitude camp, EPO concentration was measured at 24, 48,
and 72 h, and 1, 2, and 3 wk of altitude exposure, as well as the day
following return to sea level in Dallas, Texas. For logistical reasons,
in one-half of the subjects, EPO was measured in plasma by radioimmunoassay (Ramco, Houston, TX), and in the other one-half, it was
determined in serum with an enzyme-linked immunosorbent assay kit
(Human EPO Quantikine IVD, catalog no. DEP00, R&D Systems).
Comparison of the two methods and adjustments made are reported
elsewhere (17).
Training quantification and standardization. Subjects kept daily
training logs, which included training volume (recorded in units of
miles run per day) and the number of “high-intensity” workout
sessions (e.g., interval training or tempo runs performed at a pace,
subjectively determined by the athlete, as being faster than lactate
threshold pace). Before the study, each athlete and his or her coach
was given a global training template, previously used by the researchers in altitude training studies (27, 43), to design his or her individual
training plan. This template has previously been successful in matching training impulse across multiple groups living and/or training at
different altitudes. Athletes were asked to complete common work-

•

Fig. 2. Left: percent change (⌬) in 3,000-m
time trial performance at SL from prealtitude
to immediate postaltitude (open bars) and
2-wk postaltitude (shaded bars). Note that a
positive change indicates an improvement in
performance. Values are means ⫾ SE. *Significant improvement from prealtitude.
Right: percent change in maximal oxygen uptake (V̇O2max; l/min) at SL from prealtitude to
immediate postaltitude (open bars) and 2-wk
postaltitude (shaded bars). Values are mean ⫾
SE. *Significant increase from prealtitude.
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Sea level 3,000-m time trial performance significantly improved after altitude training in athletes living at 2,085 and
2,454 m at both the immediate and 2 wk postaltitude time
points (Fig. 2, left). There was no significant change in sea
level 3,000-m performance at either postaltitude time point in
groups living at the highest and lowest altitudes.
Metabolic Variables
Metabolic data during maximal exercise are displayed in
Table 2. V̇O2max, when expressed as liters per minute, improved significantly from before to after altitude training in
groups living at 2,085, 2,454, and 2,800 m, with no change in
the group living at 1,780 m (Fig. 2, right). At the 2-wk time
point after return from altitude, absolute V̇O2max was significantly higher than prealtitude in all groups. Relative V̇O2max
responses (expressed as ml·kg⫺1·min⫺1) differed slightly, due
to variations in mass changes between groups (Table 2). While

*
*
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1
0
1780m 2085m 2454m 2800m

1780m 2085m 2454m 2800m

Altitude

there was no significant change in mass from pre- to postaltitude in the 1,780-, 2,086, and 2,454-m groups, mass did
increase by 0.8 kg (P ⫽ 0.045) in the 2,800-m group. Maximal
ventilation and maximal heart rate were not different before
and after altitude training at any time point in all groups.
Individual pre- and postaltitude V̇O2max values and 3,000-m
race times for each altitude group are displayed in Fig. 3.
During submaximal exercise, steady-state V̇O2 was not different before and after altitude training at any time point in all
groups. However, V̇E during submaximal exercise was lower
or trended lower immediately postaltitude in the 1,780-m (P ⬍
0.05) and 2,085-m groups (P ⫽ 0.077) and higher postexercise
in the 2,454-m group (Fig. 4). Heart rate during submaximal
exercise was significantly lower immediately postexercise in
the 1,780- and 2,085-m groups. However, at the 2-wk postaltitude time point, heart rate during submaximal exercise was
significantly lower in the 1,780-, 2,085-, and 2,454-m groups,
but remained unchanged in the 2,800-m group.
Oxygenation During Sleep
SaO2 values obtained during sleep over the course of the
altitude camp are displayed in Fig. 5. Subjects displayed a
consistent difference in SaO2 across most time points between
the two lowest and two highest altitude groups.
EPO Response

Table 2. Metabolic variables

V̇O2max, ml·kg⫺1·min⫺1
1,780 m
2,085 m
2,454 m
2,800 m
V̇Emax, l/min BTPS
1,780 m
2,085 m
2,454 m
2,800 m
HRmax, beats/min
1,780 m
2,085 m
2,454 m
2,800 m

n

Prealtitude

Immediate
Postaltitude

2 wk Postaltitude

10
11
12
12

63.9 ⫾ 4.8
61.9 ⫾ 6.7
61.3 ⫾ 7.2
62.0 ⫾ 7.1

64.0 ⫾ 5.8
63.0 ⫾ 5.6*
63.3 ⫾ 7.8*
62.5 ⫾ 7.2

64.8 ⫾ 6.2
63.9 ⫾ 5.7*
64.6 ⫾ 7.5*
63.8 ⫾ 7.3*

10
11
12
12

137.1 ⫾ 17.0
138.9 ⫾ 22.1
139.3 ⫾ 25.2
147.7 ⫾ 28.4

139.5 ⫾ 20.2
141.6 ⫾ 21.4
140.8 ⫾ 27.7
151.0 ⫾ 28.8

140.7 ⫾ 22.6
143.2 ⫾ 21.5
144.4 ⫾ 22.5
152.3 ⫾ 27.9

10
11
12
12

196 ⫾ 10
194 ⫾ 9
197 ⫾ 9
192 ⫾ 10

194 ⫾ 11
192 ⫾ 9
197 ⫾ 9
191 ⫾ 10

196 ⫾ 9
193 ⫾ 9
195 ⫾ 10
191 ⫾ 10

Values are means ⫾ SD; n, no. of subjects. V̇Emax, minute ventilation at
maximal exercise; HRmax, maximal heart rate. *Significantly different from
prealtitude.

EPO concentrations at various altitude time points are displayed in Fig. 6. EPO significantly increased from sea level
baseline to 24 h after arriving at altitude in all four altitude groups
and remained significantly elevated over baseline after 48 h. At
the 72-h time point at altitude, EPO was still significantly elevated
in the three highest altitude groups; the 1,780-m cohort had an
EPO concentration that had returned to sea level baseline (99.8 ⫾
15.8% of sea level baseline). After 72 h of altitude exposure, EPO
was significantly higher in the group living at 2,800 m compared
with the group living at 1,780 m. Beginning with the 1-wk
through the 3-wk at altitude time points, no differences were
found between altitude and baseline EPO levels in any group.
However, on return to sea level (postaltitude), EPO levels were
significantly lower than prealtitude baseline values in all four
altitude groups. Between groups on return to sea level, EPO was
significantly lower in the 2,085- and 2,800-m cohorts than both
the 1,780- and 2,464-m groups.
Figure 7 displays the EPO responses after 24 h in the
hypobaric chamber vs. the same altitude in the field. While
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Primary Outcome Variable: 3,000-m Time Trial
Performance
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of athlete reported high intensity workouts per week was 3.8 ⫾
1.5, 3.8 ⫾ 0.8, 3.1 ⫾ 1.1, and 3.9 ⫾ 1.5 workouts in the
athletes living at 1,780, 2,085, 2,454, and 2,800 m, respectively.
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there was no difference in the mean EPO response between the
chamber and the field within each group, the responses to the
same altitude (real or simulated) showed substantial individual
variability within and across subjects.

point. Similarly, plasma volume was not different at any time
point within any of the four altitude groups.

Hematological Response

The primary finding of this investigation is that improvements in sea level endurance performance and V̇O2max after a
4-wk HiLo altitude training camp are influenced by the living
altitude utilized. Whether immediately upon return or 2 wk
after return to sea level, athlete groups who lived at the middle
of our altitude range (2,085 and 2,454 m) significantly improved mean sea level 3-km time trial performance (⬃2–3%),
while athlete groups living on the low and high ends of our
altitude range (1,780 and 2,800 m) demonstrated no changes in
sea level 3-km performance. These performance changes occurred despite equivalent increases in red cell mass within all

Erythrocyte volume, whether expressed in absolute (liters)
or relative (ml/kg) terms, was significantly increased pre- to
immediately postaltitude in all four altitude groups (Fig. 8).
However, by the 2-wk postaltitude time point, erythrocyte
volume was not significantly different from prealtitude levels
in any altitude group. There were no differences in erythrocyte
volume between altitude groups at any time point. No differences were observed in blood volume or plasma volume (in
either absolute or relative terms) between groups at any time
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Note that a positive change indicates an improvement in performance. Values are means ⫾ SE. *Significant increase from prealtitude.
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3000m Time Trial Performance (s)

1754m

Post-Alt

Fig. 3. V̇O2max (top) and 3,000-m time trial
performance (bottom). Values are from measures completed at SL and pre- and postaltitude training. Connected data points are
paired individual values for each subject.
Single data points with error bars represent
mean ⫾ SD for each condition within each
altitude group. *Significantly different from
prealtitude.
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four altitude groups, suggesting that altitude-induced erythropoiesis may be necessary, but is not sufficient by itself to
improve sea level performance. The data suggest that, when
completing an altitude camp utilizing a 4-wk HiLo training
model, there is a target living altitude between (and perhaps
around) 2,000 to 2,500 m that produces an optimal acclimatization response for sea level performance.
Is There a Threshold Altitude for Optimal Performance
Enhancement?
The lowest living altitude of 1,760 m appears to be suboptimal for improving sea level performance. The rate of EPO
formation in response to acute hypoxic exposure has been
demonstrated to be proportional to the level of hypoxic stress
(13), which matches previously published hypobaric chamber
exposure data utilizing our athlete cohort (17). In that study,
the 24-h EPO response to a simulated altitude of 1,780 m was
approximately one-third the size of the response to simulated
altitudes of 2,454 and 2,800 m. Extending this finding to
chronic altitude exposure in the field, we hypothesized that the
higher an athlete lived during an altitude training camp, the
greater the acute and chronic EPO response would be. Consistent with this hypothesis, SaO2 measured during sleep in the
field was reliably lower in the two highest living groups
compared with the two lowest altitude groups across the 4 wk
altitude camp (Fig. 5). Although all four altitude groups significantly increased EPO over sea level baseline at the 24-h
time point, EPO levels in the 1,780-m group had returned to
sea level baseline in just 72 h, while it remained elevated in the
higher altitude groups (Fig. 6). To quantify another way, over
the first 72 h at altitude, the area under the curve for EPO
relative to sea level baseline (assuming linear changes in EPO
between the 24-, 48-, and 72-h time points) was 33, 36, and
44% less for the 1,780-m group relative to the 2,085-, 2,454-,
and 2,800-m groups, respectively. This outcome would suggest
that the 1,780-m group had less erythropoietic stimulus to
increase red cell mass than the higher altitude groups.
However, in contrast to our hypothesis, measures of changes
in red cell mass after 4 wk of HiLo altitude training were ⬃6%
higher in all four altitude groups after return to sea level. We

Is There a Ceiling Altitude for Optimal Performance
Enhancement?
While our initial hypothesis presumed changes in performance and V̇O2max after 4 wk of HiLo training would be
primarily dependent on the increasing magnitude of hematological acclimatization as living altitude increased, we failed to
see an improvement in relative V̇O2max (with initial return to
sea level) or performance in the 2,800-m group. The increases
in acute and chronic EPO, as well as red cell mass, were of the
same or greater magnitude in the highest altitude group as in
the middle-altitude groups (2,085 and 2,454 m), who displayed
improved performance, suggesting hematological factors are
not the cause. The most likely explanation for the lack of
200
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Fig. 6. EPO concentration ([EPO]), expressed as a percentage of SL, prealtitude baseline, at various time points. Values are means ⫾ SE. *Significantly
different from prealtitude baseline in all four altitude groups. #Significantly
different from prealtitude baseline in the 2,085-m, 2,454-m, and 2,800-m
groups only. ⫹Significantly different from prealtitude baseline in the 2,085-m
and 2,800-m groups only.
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Fig. 5. Arterial oxyhemoglobin saturation (SaO2) measured during sleep.
Values are means ⫾ SE. Letters indicate significant differences at the same
time point at the P ⬍ 0.05 level: a 1,780 m different from 2,454 m; b 1,780 m
different from 2,800 m; c 2,085 m different from 2,454 m; d 2,085 m different
from 2,800 m.
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speculate (but cannot prove) that the amount of time spent
training at moderate altitude in these athletes may have been
enough of a supplemental hypoxic stimulus to augment the
effect of the background altitude environment. Indeed, Robertson and colleagues (38) suggested that living high in conjunction with training both high and low was a particularly
potent combination for increases in Hb mass, although their
comparison group was only athletes living low and training
high, not living high and training low. Thus the overall EPO
profile within our cohort of athletes living ⬎2,000 m was
essentially indistinguishable, at least as determined from a
single measure taken early in the morning. It also may be that
EPO has benefits on performance, independent of its effects on
erythropoiesis, such as improved cardiac and endothelial function (8), although such benefits have been difficult to isolate
(28, 35). From a methodological standpoint, a lack of differences in red cell mass between altitude groups, despite EPO
differences, may simply be a function of a lack of sensitivity of
the Evans blue dye method for determining plasma volume
(see Limitations below). Regardless of these speculations,
these observations provide further evidence that the performance enhancement from an altitude training camp is not a
linear function of the augmentation in red cell mass, which
appears to be necessary, but not sufficient, for performance
enhancement after HiLo altitude training.
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2800m

Fig. 7. [EPO], expressed as a percentage of
SL, prealtitude baseline, after 24 h in a hypobaric chamber vs. the same altitude in the
field. Connected data points are paired individual values for each subject. Single data
points with error bars represent mean ⫾ SD
for each condition within each altitude group.

50
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Field

Field

tory acclimatization, whereas, at the higher two altitudes, the
opposite was the case.
Augmented ventilatory acclimatization, as measured by
greater ventilation during submaximal exercise in the 2,800-m
group, may have negatively affected both training during the
altitude camp and race performance on return to sea level. As
ventilation increases with progressive exercise, the muscular
work necessary to ventilate the lungs increases in an exponential manner, even at altitude where air density is slightly
reduced. At very high ventilatory volumes, a small increase in
V̇E causes a disproportionate increase in both the work and
oxygen cost of breathing (1, 22). Additionally, in many elite
endurance athletes, exercise at high work rates results in the
achievement of expiratory flow limitation (10, 22). Even impending expiratory flow limitation during exercise causes the
athlete to hyperinflate the lung, increasing end-inspiratory and
end-expiratory lung volumes (30), a response that causes a
substantial increase in the work and cost of breathing (1) and
dyspnea (2). As ventilatory feedback cues are the most potent
indicator of effort and work output during exercise (33, 39), a
heightened ventilatory response to racing at sea level or training while at altitude in the 2,800-m group may have provided
a strong enough stimuli for the athletes in that cohort to
modulate work output, slowing their racing or training pace.
Ultimately, our data would suggest that endurance athletes who
live at 2,800 m (or higher) do not demonstrate a group
improvement in sea level performance after an altitude camp,
Immediate
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Fig. 8. Percent change in erythrocyte volume at SL from prealtitude to
immediate postaltitude (open bars) and 2-wk postaltitude (shaded bars). Values
are means ⫾ SE. *Significant increase from prealtitude.
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performance improvement immediately on return to sea level
in the 2,800-m group is an accumulated influence of negative
acclimatization factors related to living at this highest altitude.
Some potential factors include (but are not limited to) increased incidence of sleep apnea and other disturbances in
sleep quality/quantity or an increased incidence of mild acute
mountain sickness, both of which begin to display at threshold
altitudes below 2,800 m (5, 46). If so, the overall training
response (i.e., both the training stimulus and recovery from
training) could have been substantially poorer in the 2,800-m
group vs. the lower altitude groups. We do not have direct data
on the incidence of either impaired sleep or acute mountain
sickness in our subjects, which, if present, likely did not carry
across all 4 wk of altitude residence. However, SaO2 during
sleep was consistently lowest in the 2,800-m group at all time
points throughout the study (Fig. 5).
Additionally, our data do suggest that negative effects associated with increased ventilatory acclimatization at the highest
living altitude may be a contributing factor to the lack of
performance improvement in the 2,800-m group. With chronic
residence at altitude, ventilatory acclimatization causes a progressive, time-dependent increase in ventilation, both at rest
and at all exercise workloads (6). Generally, this increase in
ventilation is viewed as a positive adaptive benefit for altitude
residence, one that helps to defend alveolar oxygen partial
pressure and creates a higher pressure head for diffusion of O2
into the arterial blood (41). However, when the athlete ultimately returns to sea level, the gain in the ventilatory response
to exercise that developed with acclimatization to altitude often
persists as an elevated exercise V̇E, both at submaximal and
maximal workloads (19, 27, 43, 49). Interestingly, during
submaximal steady-state running in our subjects at 14.5 km/h
(9 mph), V̇E was (or trended) 3– 4% lower in the two lowest
altitude groups immediately upon return to sea level, whereas
V̇E was (or trended) 4 –5% higher in the two highest altitude
groups (Fig. 4). Submaximal steady-state HR followed a similar pattern, with significant declines (⬃2%) at the lowest two
altitudes immediately after return to sea level, and no change in
the two highest altitude groups. We believe these longitudinal
differences in the response to constant pace submaximal exercise is indicative of the balance between ventilatory and HR
responses to an increase in aerobic fitness after a 4-wk HiLo
training camp and the progressive ventilatory acclimatization
that comes from higher living altitudes. Specifically, at the
lowest two altitudes, the data suggest that the increase in
overall aerobic fitness was greater than the amount of ventila-
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ΔRed Cell Mass Volume
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EPO at 24 hrs
(% of sea level baseline)

1754m

•
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which we speculate to be due in part to negative factors
associated with acclimatization to this altitude.
Limitations

•
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that, when completing an altitude training camp, there is an
optimal living altitude for producing improvements in sea level
performance.
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